Evidence map›Paper›PMID 15803645›Full record

ReviewArchaea (Vancouver, B.C.)2002

Perspectives on biotechnological applications of archaea.

Chiara Schiraldi, Mariateresa Giuliano, Mario De Rosa

Open access · hybridAbstract readReview
In one paragraph

Review in Archaea (Vancouver, B.C.), 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 124 citations in OpenAlex.

  1. Article
  2. Biotechnological Applications of Archaea.Progress in molecular and subcellular biology · 2026
    Review
  3. Review
  4. Article
  5. Molecular Advances in Microbial Metabolism 2.0.International journal of molecular sciences · 2024
    Article
  6. Review
  7. Article
  8. 'All About' Extremophiles.Faculty reviews · 2023
    Review
  9. kFrontiers in bioengineering and biotechnology · 2023
    Article
  10. Insights into the biotechnology potential ofFrontiers in microbiology · 2022
    Review
  11. Review
  12. Haloarchaea: A Promising Biosource for Carotenoid Production.Advances in experimental medicine and biology · 2021
    Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Chiara SchiraldiDepartment of Experimental Medicine, Section of Biotechnology and Molecular Biology, Faculty of Medicine, II University of Naples, via Costantinopoli 16, 80138 Naples, Italy.
Mariateresa Giuliano
Mario De Rosa
University of Naples Federico II · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many archaea colonize extreme environments. They include hyperthermophiles, sulfur-metabolizing thermophiles, extreme halophiles and methanogens. Because extremophilic microorganisms have unusual properties, they are a potentially valuable resource in the development of novel biotechnological processes. Despite extensive research, however, there are few existing industrial applications of either archaeal biomass or archaeal enzymes. This review summarizes current knowledge about the biotechnological uses of archaea and archaeal enzymes with special attention to potential applications that are the subject of current experimental evaluation. Topics covered include cultivation methods, recent achievements in genomics, which are of key importance for the development of new biotechnological tools, and the application of wild-type biomasses, engineered microorganisms, enzymes and specific metabolites in particular bioprocesses of industrial interest.

Indexed as

ArchaeaBiotechnologyEnzymesHot TemperatureSpecies SpecificityEnzymes

Identifiers

PMID15803645
PMCPMC2685559
OpenAlexW2123160008

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.